Novalitha Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 10-12-2024
- Paid Up Capital ₹ 4.00 M
as on 10-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.70 M
as on 10-12-2024
- Revenue 65.68%
(FY 2022)
- Profit 42.70%
(FY 2022)
- Ebitda -362.70%
(FY 2022)
- Net Worth -84.28%
(FY 2022)
- Total Assets 32.89%
(FY 2022)
About Novalitha Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹2.70 M.
Surya Easarla and Veera Easarla serve as directors at the Company.
- CIN/LLPIN
U24303TG2018PTC126911
- Company No.
126911
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novalitha Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surya Easarla  | Managing Director | 20-Sep-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veera Easarla | Director | 20-Sep-2018 | Current |
Financial Performance of Novalitha Pharma.
Novalitha Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 65.68% increase. The company also saw a substantial improvement in profitability, with a 42.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 84.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novalitha Pharma?
Unlock access to Novalitha Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Mar 2020 | ₹2.70 M | Open |
How Many Employees Work at Novalitha Pharma?
Unlock and access historical data on people associated with Novalitha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novalitha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novalitha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
